Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 01, 2023
Source ID
10.1016/j.jaad.2023.02.017

Entities

People

  • Bonnie W. Leung
  • Genevieve M. Boland
  • Guihong Wan
  • Hannah Rashdan
  • Howard L. Kaufman
  • Nga Nguyen
  • Nicole R. Leboeuf
  • Riley M. Fadden
  • Ryan J Sullivan
  • Shawn G. Kwatra
  • Shijia Zhang
  • Sonia Cohen
  • Wenxin Chen
  • Yevgeniy Semenov

Organizations

  • Dermatology Foundation
  • National Cancer Institute
  • National Institutes of Health
  • United States Department of Defense